Last reviewed · How we verify
Esomeprazole 40mg
Esomeprazole 40mg is a Small molecule drug developed by Hospital General de México Dr. Eduardo Liceaga. It is currently FDA-approved. Also known as: PPI, Reference Drug, Nexium 40 mg, Nexium 40mg.
Esomeprazole 40mg is a small molecule inhibitor of the potassium-transporting ATPase, used to treat conditions such as NSAID-associated gastric ulcers, Helicobacter pylori infection, gastritis, dyspepsia, and gastric cancer. It is administered once daily, either as a 40mg dose or a 20mg dose, and has been compared to ranitidine in clinical trials for the healing of NSAID-associated gastric ulcers.
At a glance
| Generic name | Esomeprazole 40mg |
|---|---|
| Also known as | PPI, Reference Drug, Nexium 40 mg, Nexium 40mg, Nexium 40mg placebo |
| Sponsor | Hospital General de México Dr. Eduardo Liceaga |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Esomeprazole Plus Sucralfate for Post-ESD Ulcer Healing (PHASE4)
- A Randomized, Three-Arm Study Comparing Vonaprazan 10 mg, Vonaprazan 20 mg, and Esomeprazole 40 mg for the Healing of LA Grade B or Higher Reflux Esophagitis at 8 Weeks (NA)
- Efficacy and Safety of Tegoprazan and Minocycline Dual Therapy for Helicobacter Pylori Initial Treatment (PHASE4)
- Effects of High-dose Dual Therapy and Bismuth Quadruple Therapy for Helicobacter Pylori Eradication on Intestinal Microecology (PHASE4)
- Vonaprazan Versus Esomeprazole for Healing of LA Grade B or Higher Esophagitis After POEM (NA)
- The Bioavailability and Effect on Pouch pH of Esomeprazole After Gastric Bypass (PHASE4)
- Study Comparing Esomeprazole Associated With Sodium Bicarbonate From Eurofarma and Esomeprazole in Treatment of Gastroesophageal Reflux Disease ESOBIC (PHASE3)
- Keverprazan Combined with Amoxicillin for the Treatment of Helicobacter Pylori (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Esomeprazole 40mg CI brief — competitive landscape report
- Esomeprazole 40mg updates RSS · CI watch RSS
- Hospital General de México Dr. Eduardo Liceaga portfolio CI
Frequently asked questions about Esomeprazole 40mg
What is Esomeprazole 40mg?
Who makes Esomeprazole 40mg?
Is Esomeprazole 40mg also known as anything else?
What development phase is Esomeprazole 40mg in?
Related
- Manufacturer: Hospital General de México Dr. Eduardo Liceaga — full pipeline
- Also known as: PPI, Reference Drug, Nexium 40 mg, Nexium 40mg, Nexium 40mg placebo
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing